Lev Pharmaceuticals names three companies to dispense Cinryze when it is approved.
Because a Food & Drug Administration advisory committee has given approval to Lev Pharmaceuticals’ Cinryze [C1 inhibitor, (human)}, the New York company is getting ready for its final approval and distribution.
Exploring Challenges, Opportunities for Community Pharmacists in Tobacco Cessation
April 24th 2024By addressing integration barriers associated with implementing tobacco cessation programs in the community pharmacy, community pharmacists can “significantly impact public health by increasing access to effective cessation support,” wrote investigators.